SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (2274)10/10/1997 7:39:00 PM
From: Oliver & Co   of 6136
 
Hi Steve, I agree with you 100%. I was having a conversation with my broker yesterday (Nations Sec) about Auguron, and how interesting it was to me that they had taken a position on Auguron (remember that Oct 8th, Morgan Stanley/Dean Witter anounced their 1% new position in AGPH), and that since they had done this after the good news from AGPH, I had not noticed any increases in the volume or price of the stock. He said to me that the position had been acquired B4 the news were given. Now, you may ask, why am I bringing this up? Because I find it very interesting that Montgomery belongs also to the same group, ie:Nations Securities. I know that there was much info in the Toronto conference, but if you remember, it was Mr. Crosson, who in the first day of the conference downgraded the stock, that they would (or had)purchased already, and that sent it down like a rock. I am a novice in the market, but what John W. said the other day really makes sence to me. Remember that I know the drug inside and out, and that we use it very much.

Feeling Blue today, GO MARLINS!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext